High blood pressure, also known as Hypertension, is a chronic, most life-long, irreversible condition in which the force of ...

With its demonstrated clinical benefits and superior selectivity profile, SC0062 is positioned to potentially become a ...

Discover how dehydration silently destroys kidney function. Learn the hidden dangers of chronic water shortage and protect ...

First- and second-generation potassium binders reduced potassium levels in a Swedish cohort of patients, despite premature ...

The renin–angiotensin system (RAS) is a highly regulated hormonal cascade that plays a central role in the control of blood pressure and the maintenance of renal homeostasis.

With only one medication historically used to treat diabetic kidney disease, study of combination therapies with newer ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

SGLT2 inhibitors have been shown to reduce risk of acute kidney injury, but whether kidney effects are modified by risk of acute dips in eGFR is unknown.

Second BTD Recognition Highlights Compound's Potential as Next-Generation Broad-Spectrum Renal Therapy SHANGHAI, June 2 ...

Investing.com -- Mineralys Therapeutics Inc (NASDAQ: MLYS) stock surged 7.9% after reporting positive topline data from its Phase 2 Explore-CKD trial for lorundrostat in patients with hypertension and ...

Neither delivery of electronic nudge letters nor letters to general practice increase uptake of guideline-directed medical ...

Sending letters to encourage guideline-directed practice in the management of chronic kidney disease to either patients or ...